1. Cole MP: Suppression of ovarian function in primary breast cancer.In APM Forrest, PB Kunkler (eds). Prognostic Factors in Breast Cancer. E and S Livingston, Edinburgh, 1968, pp 146–156
2. Nissen-Meyer R: Suppression of ovarian function in primary breast cancer.In APM Forrest, PB Kunkler (eds). Prognostic Factors in Breast Cancer. E and S Livingston, Edinburgh, 1968, pp 139–145
3. Ravdin RG, Lewison EF, Slack NH, Dao TL, Gardner B, State P, Fisher B: Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma. Surg Gynecol Obstet 131:1055–1064, 1970
4. Meakin JW, Allt, WEC, Beale FA, Brown TC, Bush RS, Clark RM, Fitzpatrick PJ, Hawkins NV, Jenkin RDT, Pringle JF, Reid JG, Rider WD, Hayward JL, Bulbrook RD: Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast. Can Med Assoc J 120:1221–1229, 1979
5. Meakin JW, Allt WEC, Beale FA, Brown RC, Bush RS, Clark RM, Fitzpatrick PJ, Hawkins NV, Jenkin RDT, Pringle JF, Reid JG, Rider WD, Hayward JL, Bulbrook RD: Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.In HT Mouridsen, I Palsof (eds). Breast Cancer Experimental and Clinical Aspects. Pergamon, Oxford, 1980, pp 179–181